Prostate Cancer - Results from #760

RNASEH2B loss and PARP inhibition in advanced prostate cancer. June 6, 2024

Transperineal 3-Core Magnetic Resonance Imaging Ultrasound Fusion Targeted Plus Laterally 6-Core Systematic Biopsy in Prostate Cancer Diagnosis. June 6, 2024

Prostate-specific membrane antigen-PET/CT may result in stage migration in prostate cancer: performances, quantitative analysis, and potential criticism in the clinical practice. June 6, 2024

PARP inhibitors in prostate cancers, is it time for combinations? June 5, 2024

Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer. June 5, 2024

Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition. June 5, 2024

Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis. June 5, 2024

Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation. June 5, 2024

Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review. June 4, 2024

Prostate Magnetic Resonance Imaging Using the Prostate Imaging for Recurrence Reporting (PI-RR) Scoring System to Detect Recurrent Prostate Cancer: A Systematic Review and Meta-analysis. June 4, 2024

Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer. June 4, 2024

Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states. June 4, 2024

Automated prostate gland segmentation in challenging clinical cases: comparison of three artificial intelligence methods. June 4, 2024

An artificial intelligence model for detecting pathological lymph node metastasis in prostate cancer using whole slide images: a retrospective, multicentre, diagnostic study. June 4, 2024

An integrated radiology-pathology machine learning classifier for outcome prediction following radical prostatectomy: Preliminary findings. June 4, 2024

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. June 4, 2024

Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study). June 3, 2024

Patient-reported Outcome Measures and Experience Measures After Active Surveillance Versus Radiation Therapy Versus Radical Prostatectomy for Prostate Cancer: A Systematic Review of Prospective Comparative Studies. June 3, 2024

Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. June 3, 2024

International Variations in Surgical Quality of Care in Men With Prostate Cancer: Results From the TrueNTH Global Registry. June 3, 2024

Page 39 of 1435